Siglec‐G Suppresses CD8+ T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy.

Saved in:
Bibliographic Details
Title: Siglec‐G Suppresses CD8+ T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy.
Authors: Yin, Shenhui1 (AUTHOR), Li, Chunzhen1 (AUTHOR), Shen, Xin1 (AUTHOR), Yu, Guanyu2 (AUTHOR), Cui, Likun1 (AUTHOR), Wu, Yunyang1 (AUTHOR), He, Yixian1 (AUTHOR), Yu, Shu1 (AUTHOR), Chen, Jie1 (AUTHOR), Lu, Shaoteng1 (AUTHOR), Qiu, Guifang1 (AUTHOR), Song, Mengqi1 (AUTHOR), Qian, Cheng1 (AUTHOR), Zou, Zui3,4 (AUTHOR) zouzui@smmu.edu.cn, Yu, Yizhi1 (AUTHOR) yuyz@immunol.org, Xu, Sheng1 (AUTHOR) xusheng@immunol.org
Source: Advanced Science. 12/4/2024, Vol. 11 Issue 45, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21983844
DOI:10.1002/advs.202403438